A 12-week, multicenter study to evaluate the efficacy and safety of orally administered valsartan/amlodipine combo based therapy vs amlodipine monotherapy in black patients with stage II hypertension.
Phase of Trial: Phase III
Latest Information Update: 07 Nov 2011
At a glance
- Drugs Amlodipine/valsartan (Primary) ; Amlodipine
- Indications Hypertension
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Novartis
- 07 Nov 2011 Actual end date (Apr 2007) added as reported by ClinicalTrials.gov.
- 04 Jun 2007 Status changed from in progress to completed.
- 10 Jul 2006 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History